CRISPR Therapeutics Announces Chief Financial Officer Transition
CRISPR Therapeutics announced CFO Raju Prasad is stepping down effective immediately to pursue external opportunities. A.J. Silver, SVP of Finance since January 2025 and with the company since 2018, succeeds him as CFO, giving the transition an internal-succession character.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.